journal article·2022-05

Magnesium oxide regulates the degradation behaviors and improves the osteogenesis of poly(lactide-co-glycolide) composite scaffolds

Xue Xia, Jinhui Huang, Jiawei Wei, Shue Jin, Qin Zou, Yi Zuo, Jidong Li, Yubao Li

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Convergence of scaffold-guided bone regeneration and RIA bone grafting for the treatment of a critical-sized bone defect of the femoral shaft10.1186/s40001-020-00471-w ↗
2. Synthetic bone graft substitutes10.1046/j.1440-1622.2001.02128.x ↗
3. Bone regeneration of hollow tubular magnesiumstrontium scaffolds in critical-size segmental defects: effect of surface coatings10.1016/j.msec.2019.02.067 ↗
4. 3D bioactive composite scaffolds for bone tissue engineering
5. Degradable porous drug-loaded polymer scaffolds for localized cancer drug delivery and breast cell/tissue growth10.1016/j.msec.2020.110794 ↗
6. Biomimetic materials for bone tissue engineering - state of the art and future trends10.1002/adem.201080098 ↗
7. PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits10.1016/j.actbio.2013.01.024 ↗
8. An osteoconductive PLGA scaffold with bioactive beta-TCP and anti-inflammatory Mg(OH)2 to improve in vivo bone regeneration10.1039/C9BM01864F ↗
9. An overview of poly(lactic-co-glycolic) acid (PLGA)-Based biomaterials for bone tissue engineering10.3390/ijms15033640 ↗
10. Current uses of poly (lactic-co-glycolic acid) in the dental field: a comprehensive review10.1155/2015/525832 ↗
11. Reduction of inflammatory reaction of poly (d,l-lactic-co-glycolic Acid) using demineralized bone particles10.1089/tea.2007.0129 ↗
12. Preparation, physicochemical properties and biocompatibility of PBLG/PLGA/bioglass composite scaffolds10.1016/j.msec.2016.09.085 ↗
13. Effects of HAp and TCP in constructing tissue engineering scaffolds for bone repair10.1039/C7TB00790F ↗
14. Surface modification of porous PLGA scaffolds with plasma for preventing dimensional shrinkage and promoting scaffold-cell/tissue interactions10.1039/C8TB02374C ↗
15. Recommendations and considerations for the use of biologics in orthopedic surgery10.1007/BF03261883 ↗
16. Effect of sodium chloride as a porogen agent in mechanical properties of PLGA/HA nanocomposite scaffolds10.1088/2057-1976/ab61c1 ↗
17. Preparation and in vitro degradation of PLGA/HA composite fiber scaffolds by electrospinning10.4028/www.scientific.net/AMR.591-593.982 ↗
18. Fabrication of nanocrystalline hydroxyapatite doped degradable composite hollow fiber for guided and biomimetic bone tissue engineering10.1016/j.msec.2006.05.024 ↗
19. Fabrication and characteristics of anti-inflammatory magnesium hydroxide incorporated PLGA scaffolds formed with various porogen materials10.1007/s13233-014-2040-y ↗
20. Addition of MgO nanoparticles and plasma surface treatment of three-dimensional printed polycaprolactone/hydroxyapatite scaffolds for improving bone regeneration10.1016/j.msec.2016.12.054 ↗
21. Effect of magnesium hydroxide nanoparticles with rod and plate shape on mechanical and biological properties of poly(L-lactide) composites10.1007/s13233-014-2140-8 ↗
22. Biodegradable magnesium-incorporated poly(l-lactic acid) microspheres for manipulation of drug release and alleviation of inflammatory response10.1021/acsami.9b03766 ↗
23. Role of magnesium in genomic stability10.1016/S0027-5107(01)00074-4 ↗
24. Surface degradation enabled osseointegrative, angiogenic and antiinfective properties of magnesium- modified acrylic bone cement
25. Use of a three-dimensional printed polylactide-coglycolide/tricalcium phosphate composite scaffold incorporating magnesium powder to enhance bone defect repair in rabbits
26. Overview of methods for enhancing bone regeneration in distraction osteogenesis: potential roles of biometals
27. Morphology and composition of nanograde calcium phosphate needle-like crystals formed by simple hydrothermal treatment10.1007/BF00058956 ↗
28. Evaluating and modeling the mechanical properties of the prepared PLGA/nano-BCP composite scaffolds for bone tissue engineering10.1016/S1005-0302(12)60004-8 ↗
29. Enhanced biological and mechanical properties of well-dispersed nanophase ceramics in polymer composites: from 2D to 3D printed structures10.1016/j.msec.2010.07.013 ↗
30. The long-term behaviors and differences in bone reconstruction of three polymer-based scaffolds with different degradability10.1039/C9TB02072A ↗
31. Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds10.1016/j.biomaterials.2006.10.003 ↗
32. The pore size of PLGA bone implants determines the de novo formation of bone tissue in tibial head defects in rats10.1002/mrm.24541 ↗
33. Synthesis and characterization of poly (D,L-Lactide-co-Glycolide) copolymer10.4236/jbnb.2012.32027 ↗
34. Plasmon induced enhanced photocatalytic activity of gold loaded hydroxyapatite nanoparticles for methylene blue degradation under visible light10.1039/C6RA28640B ↗
35. A novel hydroxyapatite –Hardystonite nanocomposite ceramic10.1016/j.ceramint.2015.01.033 ↗
36. Effects of strontium substitution on the phase transformation and crystal structure of calcium phosphate derived by chemical precipitation10.1016/j.ceramint.2016.04.116 ↗
37. A new facile synthesis of ultra fine magnesium oxide nanowires and optical properties10.1007/s10832-012-9761-0 ↗
38. Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells10.1002/jat.2958 ↗
39. Defluoridation of water using nano-magnesium oxide10.1080/17458080.2012.675522 ↗
40. Surface hydrophilicity of PLGA fibers governs in vitro mineralization and osteogenic differentiation10.1016/j.msec.2014.08.074 ↗
41. Mechanical properties of cancellous bone from the acetabulum in relation to acetabular shell fixation and compared with the corresponding femoral head10.1016/j.medengphy.2018.01.005 ↗
42. Biodegradation and biocompatibility of PLA and PLGA microspheres10.1016/S0169-409X(97)00048-3 ↗
43. Integration of porosity and bio-functionalization to form a 3D scaffold: cell culture studies and in vitro degradation10.1088/1748-6041/5/4/045001 ↗
44. Technique to control pH in vicinity of biodegrading PLA-PGA implants10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U ↗
45. In vitro degradation and cytocompatibility of g-MgO whiskers/PLLA composites10.1007/s10853-016-0525-0 ↗
46. Concentration-dependent behaviors of bone marrow derived mesenchymal stem cells and infectious bacteria toward magnesium oxide nanoparticles10.1016/j.actbio.2016.02.032 ↗
47. The osteogenic potential of mesoporous bioglasses/silk and non-mesoporous bioglasses/silk scaffolds in ovariectomized rats: in vitro and in vivo evaluation10.1371/journal.pone.0081014 ↗
48. Osteoimmunology in bone fracture healing10.1007/s11914-017-0381-0 ↗
49. A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls10.1210/jc.2006-1391 ↗
50. Magnesium ion stimulation of bone marrow stromal cells enhances osteogenic activity, simulating the effect of magnesium alloy degradation10.1016/j.actbio.2014.02.002 ↗
51. Magnesium substitution in the structure of orthopedic nanoparticles: a comparison between amorphous magnesium phosphates, calcium magnesium phosphates, and hydroxyapatites10.1016/j.msec.2015.03.032 ↗